NPI Details
DR. Andrew Stephen Levine, M.D. is a pain medicine pain medicine in Bellaire, TX. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. DR. Andrew Stephen Levine, M.D. NPI is 1285781872. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
5959 WEST LOOP S STE 375
BELLAIRE, TX
ZIP 77401-403
Phone: (713) 665-3131
Fax: (713) 665-3164
The NPI 1285781872 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
- Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
- Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg (HCPCS:J7325)
- Aspiration and/or injection of fluid from large joint (HCPCS:20610)
- Fluoroscopic guidance for needle placement (HCPCS:77002)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
- Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose (HCPCS:J7324)
- Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
The enumeration date for this NPI number is 1/4/2007 and was last updated on 9/1/2021.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 208VP0000X | Pain Medicine | Pain Medicine | E5827 | TEXAS | Yes |
| 2 | 207X00000X | Orthopaedic Surgery | | E5827 | TEXAS | No |
